Exchange: NYSE·Updated 03:59 PM EDT

CFX Colfax Corporation

$23.92
$0.79
(3.20%)
Today
Closed $23.87
$0.05
(0.21%)
After Hours
Mkt Cap$1.41B
Vol39,135.00

About CFX

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
50

Neutral Sentiment

How do you feel about CFX?

Advertisement|Remove ads.